Pre-operative pain management with nerve block in patients with hip fractures: a randomized, controlled trial.
Autor: | Wennberg P; Research and Development Centre, Skaraborg Hospital, Skövde, Sweden; University Health Care Research Centre, Region Örebro, and School of Health Sciences, Örebro University, Sweden. Electronic address: par.wennberg@vgregion.se., Norlin R; Capio Movement, Halmstad, Sweden; Department of Orthopedics, Örebro University Hospital, and Örebro University, Sweden. Electronic address: rolf.norlin@gmail.com., Herlitz J; The Centre of Prehospital Research in Western Sweden, University College of Borås, Sweden; The Centre of Prehospital Research in Western Sweden, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: johan.herlitz@hb.se., Sarenmalm EK; Research and Development Centre, Skaraborg Hospital, Skövde, Sweden. Electronic address: elisabeth.kenne.sarenmalm@vgregion.se., Möller M; University Health Care Research Centre, Region Örebro, and School of Health Sciences, Örebro University, Sweden. |
---|---|
Jazyk: | angličtina |
Zdroj: | International journal of orthopaedic and trauma nursing [Int J Orthop Trauma Nurs] 2019 May; Vol. 33, pp. 35-43. Date of Electronic Publication: 2018 Nov 28. |
DOI: | 10.1016/j.ijotn.2018.11.003 |
Abstrakt: | Introduction: Pain management in patients with hip fractures is a major challenge for emergency care. The objective of this study was to evaluate whether the supplementation of pre-operative analgesia with low-dose fascia iliaca compartment block (FICB) compared with placebo would improve pain relief in patients with hip fractures. Methods: A double-blind, randomized, controlled trial was conducted on 127 patients. At hospital admission, a low-dose FICB was administered to patients with hip fractures as a supplement to regular pre-operative analgesia. Patients with and without cognitive impairment were included. The instruments used were a visual analogue scale (VAS), a numerical rating scale and a tool for behavior related pain assessment. The primary endpoint was the change in reported pain on movement from hospital admission to two hours after FICB. Results: The intervention group showed improved pain management by mean VAS score for pain on movement compared with the control group (p = 0.002). Conclusions: Our results support the use of low-dose FICB as a pain-relieving adjuvant to other analgesics when administered to patients with a hip fracture. (Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |